Explore how genetic testing, Lp(a), and innovative screening methods are transforming lipid management and cardiovascular risk prevention. Learn when and how to initiate treatment across diverse populations, and enhance your role in delivering proactive, precision-based care.
Learning Objectives
- Discuss the role of genetic testing in screening for lipid abnormalities in individuals and families
- Review lipid treatment considerations including when to start lipid lowering therapies, treatment in special population (i.e. adolescents or pregnancy) and how to apply additional screening tools such as genetic testing or CACs.
- Examine the impact of Lp(a) on CVD risk and treatment
- Explore the future of cardiovascular risk management and the role of the interdisciplinary team
CE certificate available upon successful completion of the post-test and program evaluation.
Accreditation:
PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.
